Dr. Daneshmand on Blue Light Cystoscopy for Bladder Cancer

Siamak Daneshmand, MD
Published: Friday, May 26, 2017


 Siamak Daneshmand, MD, associate professor of Urology, Director of Clinical Research, Keck School of Medicine of USC, discusses blue light cystoscopy compared with white light cystoscopy for patients with bladder cancer.

This phase III study involved 304 patients at 17 leading institutions in the United States, explains Daneshmand. The objective was to determine if blue light cystoscopy increased the detection of bladder tumors.

Patients first underwent white light cystoscopy and then would have blue light cystoscopy done, states Daneschmand. The number and character of lesions were determined and compared with the number seen in the operating room.


 Siamak Daneshmand, MD, associate professor of Urology, Director of Clinical Research, Keck School of Medicine of USC, discusses blue light cystoscopy compared with white light cystoscopy for patients with bladder cancer.

This phase III study involved 304 patients at 17 leading institutions in the United States, explains Daneshmand. The objective was to determine if blue light cystoscopy increased the detection of bladder tumors.

Patients first underwent white light cystoscopy and then would have blue light cystoscopy done, states Daneschmand. The number and character of lesions were determined and compared with the number seen in the operating room.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Cancer Summaries and Commentaries™: Update from Chicago: Advances in the Treatment of Breast CancerJul 31, 20181.0
Community Practice Connections™: The Next Generation in Renal Cell Carcinoma Treatment: An Oncology Nursing Essentials WorkshopJul 31, 20181.5
Publication Bottom Border
Border Publication
x